Akso Health (AHG) EBIT (2017 - 2019)

Akso Health (AHG) has reported EBIT for 3 consecutive years, with -$10.3 million the latest figure, recorded in Q3 2019.

• Quarterly EBIT rose 41.06% year-over-year to -$10.3 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was -$40.3 million (down 157.01% YoY) and the FY2026 annual result came in at -$20.7 million, up 87.55% from the prior year.
• EBIT slipped to -$10.3 million in Q3 2019 per AHG's latest filing, from -$1.4 million in the prior quarter.
• Over the last five years, EBIT for AHG reached as high as $36.1 million in Q2 2018 and fell as low as -$17.5 million in Q3 2018.
• A 3-year average of $8.1 million and a median of $10.3 million in 2017 frame the typical range for EBIT.
• The largest YoY upside for EBIT was 249.93% in 2018 against a maximum downside of 218.92% in 2018.
• Year by year, EBIT stood at $31.6 million in 2017, then sank by 135.23% to -$11.1 million in 2018, then gained by 7.68% to -$10.3 million in 2019.
• According to Business Quant data, EBIT over the past three periods registered -$10.3 million, -$1.4 million, and -$11.1 million for Q3 2019, Q1 2019, and Q4 2018 respectively.